AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 125 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,751,000 | +66.4% | 120,000 | +26.3% | 0.54% | +25.9% |
| Q1 2018 | $2,855,000 | -3.8% | 95,000 | 0.0% | 0.43% | +24.4% |
| Q4 2017 | $2,969,000 | +11.6% | 95,000 | 0.0% | 0.35% | -8.4% |
| Q3 2017 | $2,661,000 | -7.3% | 95,000 | -36.7% | 0.38% | -22.1% |
| Q2 2017 | $2,870,000 | +7.4% | 150,000 | 0.0% | 0.49% | +12.2% |
| Q3 2016 | $2,672,000 | – | 150,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
| GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
| Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
| Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
| Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
| Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
| Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
| Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
| PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
| Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |